Mountain West AIDS Education and Training Center (MWAETC)

OD presentation return node

« Return to MWAETC On-Demand Presentations

Fostemsavir (Rukobia): The How, Why, and When of Using this Novel Antiretroviral (ARV) to Treat HIV

Presentation Date: 2020-07-16

Presentation Length: 14:48

Presenters: Dave Hachey, PharmD

Presentation Categories: HIV ECHO

Presentation Tags: Anti-Retroviral Therapy (ART)

Presentation Slides:

Download (1.743 MB)

Presentation Downloads:

Related Documents:

Related Links:

Related Presentations:

Presentation Details:
David Hachey, PharmD, reviews data for fostemsavir (Rukobia), an attachment inhibitor now approved for HIV treatment, and highlights important clinical considerations for use of this novel antiretroviral (ARV).

Presentation Transcript:

MOUNTAIN WEST AIDS EDUCATION AND TRAINING CENTER

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $2,982,063 with 0% financed with non-governmental sources. The content in presentations are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government.